Drug discovery

#Biotechnology #Cancer research #Clinical trials #Drug development #Drug discovery #Drug targets #Opinion #Podcasts

The DDW Podcast: 2024 in review

As 2024 draws to a close, DDW’s Multimedia Editor and podcast host Megan Thomas rounds up all the free editorial episodes of the DDW podcast that were released. You can find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. DDW Highlights Innovative. Evolving. Developing. Busy. These… Read More

#News

AI and robotics
#AI / data analytics / healthtech / informatics #Automation #Biotech #Drug development #Drug discovery #Regulatory

Unsustainable regulatory workloads leave no choice about AI adoption 

To determine where pharma/biopharma regulatory functions see the greatest potential for AI technology, ArisGlobal commissioned an exclusive survey1 of senior regulatory professionals in US pharma and biopharma organisations. The research was conducted in early September 2024. Discussing the findings, Renato Rjavec from ArisGlobal notes that, although… Read More

#Exclusive Content #Regulatory

#Drug discovery

Ebook: mRNA Uses and innovation for this technology in drug discovery

The success of mRNA-based vaccines for COVID-19 pushed messenger RNA into the spotlight. However, its uses in drug discovery and development aren’t just confined to vaccines – applications include personalised medicine and therapeutics, for example. This eBook, sponsored by Promega, examines the latest innovations that are driving the mRNA drug… Read More

#DDW eBooks

AI concept
#Artificial intelligence (AI) #Cradle #Drug discovery #Funding #Machine learning #Protein engineering

Generative AI unlock the impact of engineered biology

Cradle, an AI-powered platform for protein engineering, has raised $73m in Series B funding to respond to rising demand in R&D intensive industries. This funding takes the total raised to date over $100m. The round was led by IVP with participation from previous investors Index Ventures and Kindred Capital. Proteins… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Amazon Web Services (AWS) #Artificial intelligence (AI) #Drug development #Drug discovery #Generative AI

Register now: The benefits of generative AI in drug discovery

In this webinar, discover how high-performance computing (HPC) and AI are being used to screen out potentially dangerous drugs, improve the identification of drug candidates, and develop new therapeutic compounds. It can take years, and cost billions, to get new drugs approved for clinical use, but technological… Read More

Webinar date:
Supported by Amazon Web Services and NVIDIA
#News

FDA
#Clinical trial #Drug discovery #FDA #Regulatory #SpliceBio #Stargardt disease

First-ever FDA IND for a protein splicing gene therapy

The US Food & Drug Administration (FDA) has cleared an investigational new drug (IND) application for SpliceBio’s lead programme SB-007, a clinical-stage therapeutic addressing the root genetic cause of Stargardt disease with the potential to treat all patients across all ABCA4 mutations. The SpliceBio study uses protein splicing to address… Read More

#News #Regulatory #Trending News

#Drug discovery #Immunology / Virology & Vaccines

Webinar: Structural characterisation of a novel class of antibacterials that target MsbA in multidrug-resistant Acinetobacter baumannii – Thermo Fisher Scientific – 11.12.2024

In this webinar, hosted by DDW and supported by Thermo Fisher Scientific, you will learn about the current advancements taking place in antibiotic drug discovery. This event will highlight how cryo-electron microscopy (cryo-EM) can be used to target the lipopolysaccharide transporter MsbA in multidrug-resistant Acinetobacter baumannii. This pathogen is a… Read More

#Webinars

#Drug discovery

App Note: Efficient screening of copolymer nanodiscs to optimize membrane proteins for cryo-EM

With the use of innovative solubilization approaches, such as synthetic copolymers, structural biologists can efficiently create soluble membrane proteins optimized for cryo-EM workflows. In this application note, learn how to screen for the optimal copolymers using a combination of parameters from the Prometheus Panta instrument for stability characterization of membrane proteins. Read More

#App Notes

#Assays #Drug discovery #eBook #Lab equipment #Microplates

eBook: Enhance microplate performance

A new eBook is now free to download from Aurora Microplates. In this eBook, the company explores the three critical areas that scientists must pay attention to when selecting the right microplate. Material Purity: Not all microplate materials are equal and impurities in plastics can affect cell health Plate… Read More

#News

#Assays #Drug discovery #Lab equipment #Microplates

Enhance microplate performance by understanding key factors that affect outcomes of scientific research

In this eBook we explore the three critical areas that scientists must pay attention to when selecting the right microplate. Material Purity: Not all microplate materials are equal and impurities in plastics can affect cell health Plate Design: Flatness is crucial to capture high quality images especially with HTS &… Read More

#Resources

#Animal models #Drug development #Drug discovery #The Jackson Laboratory #Vodcast

New vodcast on AI-powered home cage monitoring

The latest sponsored DDW Sitting Down With vodcast features Michael Ellis, Senior Director of R&D at The Jackson Laboratory (JAX), and Timothy Robertson, CEO of TLR Ventures and Leader of the Digital In Vivo Alliance to introduce their new digital home cage monitoring system, Envision. Both Ellis and… Read More

#News

#Drug development #Drug discovery #Interview #Sitting Down With #The Jackson Laboratory #Vodcast

Vodcast: Revolutionising preclinical research with AI-powered home cage monitoring

The latest sponsored DDW Sitting Down With vodcast features Michael Ellis, Senior Director of R&D at The Jackson Laboratory (JAX), and Timothy Robertson, CEO of TLR Ventures and Leader of the Digital In Vivo Alliance to introduce their new digital home cage monitoring system, Envision. Both Ellis and… Read More

#Videos

#Artificial intelligence (AI) #BenevolentAI #Business #Drug discovery

BenevolentAI announces layoffs as it plans to delist and refocus

BenevolentAI has unveiled a major strategic overhaul, which it says will return the company to its founding TechBio mission.   The company has initiated significant organisational and budgetary changes that extend into 2027 and is also exploring options to delist from Euronext Amsterdam.  Kenneth Mulvany, Executive… Read More

#Business & Investment #News #Trending News

#Drug discovery

Webinar: Characterization of CAR-T cells: Integrating live-cell analysis and high-throughput cytometry – Sartorius – 05.12.2024

The development of gene-modified cell therapies, particularly CAR-T cells, has transformed cancer treatment by offering personalized and potentially curative options.  This webinar, hosted by DDW and supported by Sartorius, explores the integration of live-cell analysis and high-throughput screening (HTS) by cytometry to enhance the characterization of CAR-T cells. Key topics… Read More

#Webinars

#Artificial intelligence (AI) #CAR-T #Drug discovery #Exosomes #Oncology #Weight loss

New DDW Highlights podcast: 9 December 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week’s leading news stories all shine a light on… Read More

#News